• Resveratrol’s Hormetic Rescue of Radiation-Induced Endotheli

  2026-05-01

  This study establishes a robust in vitro model to evaluate radiation-induced vascular injuries and demonstrates that resveratrol exerts a hormetic, dose-dependent rescue effect on endothelial DNA and tube integrity. The findings optimize screening for radioprotective compounds and have implications for therapeutic development in mitigating radiation damage.

• BIIE 0246: Redefining Y2 Receptor Antagonism for Translation

  2026-05-01

  Explore the advanced utility of BIIE 0246 as a neuropeptide Y Y2 receptor antagonist, uniquely positioned for translational neuroscience and cardiac arrhythmia modeling. This article provides deep mechanistic insight and practical guidance beyond standard assay applications.

• BET Bromodomain Inhibition: Mechanistic Insights & Translati

  2026-04-30

  This thought-leadership article explores the strategic integration of Bromodomain Inhibitor, (+)-JQ1 in translational research. We blend mechanistic dissection of BET bromodomain inhibition—anchored in recent super-enhancer biology and apoptosis workflows—with actionable guidance for researchers navigating adipogenesis, inflammation, and non-hormonal male contraception. Leveraging landmark evidence and workflow-driven recommendations, this article positions APExBIO’s (+)-JQ1 as a pivotal tool for data-driven innovation, expanding the discussion beyond conventional product literature and into the vanguard of epigenetic modulation.

• Nanozyme-Functionalized Hydrogel Disrupts ROS-Ferroptosis Cy

  2026-04-30

  This study introduces a nanozyme-functionalized hydrogel capable of breaking the reactive oxygen species (ROS)-ferroptosis-inflammation cycle in intervertebral disc degeneration (IDD). By leveraging a black phosphorus@cerium oxide nanozyme, the approach offers durable antioxidant defense and disrupts pathological signaling, providing a promising new route for disc repair.

• Metal Ion-Mediated Enrichment Boosts mRNA Vaccine Efficacy

  2026-04-29

  The referenced study introduces a manganese ion-based strategy to significantly enhance mRNA loading in lipid nanoparticles (LNPs), nearly doubling the payload compared to existing formulations. This approach reduces lipid dosage and associated toxicity while improving vaccine efficacy, offering a robust platform for next-generation mRNA therapeutics.

• N2-Alkyl-dG Lesions Promote R-Loop Accumulation and Genome I

  2026-04-29

  This study reveals that minor-groove N2-alkyl-dG DNA lesions drive the accumulation of R-loops in human cells. These findings highlight a previously unrecognized pathway by which alkylating DNA damage perturbs genome stability, providing new mechanistic insights into DNA damage responses and potential therapeutic targets.

• Panobinostat Targets RNF20/RNF40/WAC Axis in MLL-ALL Therapy

  2026-04-28

  This study demonstrates that the HDAC inhibitor panobinostat exerts potent anti-leukaemic effects in vivo against MLL-rearranged acute lymphoblastic leukaemia (ALL) by disrupting the RNF20/RNF40/WAC-H2B ubiquitination axis. These findings inform targeted epigenetic therapy strategies and highlight practical opportunities for mechanistic studies of cell cycle and apoptosis in aggressive infant leukaemia.

• Staurosporine: Broad-Spectrum Kinase Inhibitor for Cancer Re

  2026-04-28

  Staurosporine is a potent broad-spectrum serine/threonine protein kinase inhibitor widely used in cancer research. It induces apoptosis in mammalian cell lines and inhibits VEGF receptor autophosphorylation, supporting its role as an anti-angiogenic agent. APExBIO’s Staurosporine (SKU A8192) offers reproducible inhibition profiles for translational workflows.

• Puerarin Regulates Gut Microbiota and Adipose Thermogenesis

  2026-04-27

  This study demonstrates that puerarin improves glucose and lipid metabolism in type 2 diabetes (T2D) mice by restoring gut microbiota balance and activating adipose tissue thermogenesis pathways. Through multi-omics and protein analysis, the research identifies specific microbial and molecular targets, highlighting new therapeutic avenues for metabolic disease intervention.

• Azilsartan Medoxomil Monopotassium: Precision in Hypertensio

  2026-04-27

  This thought-leadership article delivers an evidence-backed synthesis on Azilsartan medoxomil monopotassium (TAK 491), spotlighting its mechanistic precision, experimental strengths, and strategic advantages for translational hypertension and cardiovascular disease research. By integrating new quantitative insights and workflow best practices, and directly referencing both peer-reviewed and scenario-driven content, we empower researchers to leverage this advanced AT1 receptor antagonist for reproducible, forward-thinking blood pressure regulation studies. APExBIO’s SKU B1071 is positioned as a rigorously validated tool, bridging molecular pharmacology to translational endpoints with a focus on reliability, selectivity, and future-ready experimental design.

• Reactive Oxygen Species Assay Kit: Precision in Oxidative St

  2026-04-26

  Unlock high-sensitivity detection of intracellular superoxide using the APExBIO Reactive Oxygen Species Assay Kit (DHE). Discover advanced workflow strategies, troubleshooting insights, and unique applications for immunotoxicity and redox pathway research.

• Advances in In Vitro Drug Response Evaluation for Cancer Res

  2026-04-25

  Schwartz's dissertation introduces a rigorous comparison of relative versus fractional viability metrics in in vitro drug response assays, revealing that proliferation arrest and cell death are distinct yet interrelated readouts. This work clarifies methodological choices that will refine how researchers interpret the efficacy of anti-cancer agents and guides the rational selection of assay endpoints.

• AI-Based Urine Stem Cell Mitochondrial Imaging for AD Biomar

  2026-04-24

  This study introduces a deep learning framework for analyzing mitochondrial morphology in urine-derived stem cells (USCs), aiming to establish a non-invasive biomarker for Alzheimer’s disease (AD). The approach leverages high-content fluorescence imaging and convolutional neural networks to classify mitochondrial dynamics, offering a promising early detection strategy for AD.

• Cy5 NHS ester(Et): Technical Guide for Protein Fluorescent L

  2026-04-24

  Cy5 NHS ester(Et) enables robust, water-soluble fluorescent labeling of biomolecules via primary amines, streamlining workflows in immunofluorescence, flow cytometry, and fluorescence microscopy. It is unsuitable for ethanol-based protocols and should not be stored in solution long-term. Use is best restricted to applications where high labeling efficiency and prompt use are required.

• Roscovitine (Seliciclib): Driving Cell Cycle Arrest in Cance

  2026-04-23

  Roscovitine (Seliciclib, CYC202) offers precise, reversible cell cycle control and robust tumor growth inhibition for advanced cancer biology workflows. Its selective CDK targeting and validated in vivo utility empower researchers to dissect cell cycle checkpoints and test novel immuno-oncology combinations with confidence.

11364 records 1/758 page Next 12345 下5页 Last page